Table 2.
Comparison of patients with ascending aorta dilatation and control individuals in terms of biochemical and hematological characteristics
| Group I Dilatation (-) (n=178) |
Group II Dilatation (+) (n=169) |
P Value | |
| Glucose, mg/dL | 102 ± 46.1 | 100 ± 24.3 | 0.645 |
| Creatinine, mg/dL | 0.92 ± 0.23 | 0.98 ± 0.24 | 0.028 |
| LDL, mg/dL | 106 ± 37 | 112 ± 30 | 0.094 |
| HDL, mg/dL | 45 ± 12 | 45 ± 11 | 0.824 |
| Hemoglobin, g/dL | 14 ± 1.6 | 13 ± 1.7 | 0.421 |
| Platelet, x103/L | 242 ± 61 | 241 ± 62 | 0.833 |
| WBC, x109/L | 7.7 ± 2.1 | 7.5 ± 2.0 | 0.327 |
| Monocyte, x109/L | 0.55 ± 0.19 | 0.67 ± 0.40 | 0.001 |
| Monocyte/ HDL Ratio | 13.0 ± 5.9 | 15.0 ± 10.3 | <0.001 |
| Uric acid | 4.5 ± 1.62 | 5.2 ± 1.77 | 0.001 |
| C-reactive protein | 5.3 ±11.4 | 10.1 ± 27.8 | 0.032 |
*LDL, low density lipoprotein; HDL, high density lipoprotein; WBC, white blood cell.
*Data are expressed as the median (25th percentile- 75th percentile)) for not normally distributed and mean ± standard deviation or frequency for other factors. Significant difference if p<0.05.